Buy Syngene International, target price Rs 660: Yes Securities

Buy Syngene International, target price Rs 660: Yes Securities

news image

Synopsis

Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.

ThinkStock Photos
Promoters held 70.42 per cent stake in the company as of 30-Sep-2021, while FIIs owned 14.23 per cent, DIIs 4.66 per cent.

Yes Securities has buy call on

International with a target price of Rs 660. The current market price of Syngene International is Rs 622.6.

Time period given by analyst is Intra Day when Syngene International Ltd. price can reach defined target.

Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.

Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2021.

Financials

For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 623.10 Crore, up 2.69 % from last quarter Total Income of Rs 606.80 Crore and up 16.82 % from last year same quarter Total Income of Rs 533.40 Crore. Company reported net profit after tax of Rs 66.70 Crore in latest quarter.

Investment Rationale
The appearance of a large bullish candle and swift reversal from the lower levels in the recent past suggests a resumption of uptrend

Promoter/FII Holdings
Promoters held 70.42 per cent stake in the company as of 30-Sep-2021, while FIIs owned 14.23 per cent, DIIs 4.66 per cent.

(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.

(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

moreless

Pick the best stocks for yourself

Powered by

  • 5 stocks with consistent score improvement and upside potential of up to 38%

    5 mins read

  • Check out how bank stocks are faring according to Stock Reports Plus

    3 mins read

  • Bullish on banks? Find out what analysts are saying about Nifty Bank stocks

    3 mins read

  • Check out which Nifty50 stocks analysts recommend buying this week

    2 mins read

  • Weekly Top Picks: Stocks with 10 on 10 score on Stock Reports Plus

    2 mins read

  • Looking to bet on banks? Here are top recommendations from analysts

    3 mins read

  • Largecap stocks that can rally up to 45% in next 12 months

    4 mins read

  • IT stocks showing strong resilience amid market volatility

    3 mins read

SynopsisSyngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.ThinkStock PhotosPromoters held 70.42 per cent stake in the company as of 30-Sep-2021, while FIIs owned 14.23 per cent, DIIs 4.66 per cent.Yes Securities has buy call on International with a target price of Rs 660. The current market price of Syngene International is Rs 622.6. Time period given by analyst is Intra Day when Syngene International Ltd. price can reach defined target. Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector. Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2021. Financials For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 623.10 Crore, up 2.69 % from last quarter Total Income of Rs 606.80 Crore and up 16.82 % from last year same quarter Total Income of Rs 533.40 Crore. Company reported net profit after tax of Rs 66.70 Crore in latest quarter. Investment RationaleThe appearance of a large bullish candle and swift reversal from the lower levels in the recent past suggests a resumption of uptrend Promoter/FII Holdings Promoters held 70.42 per cent stake in the company as of 30-Sep-2021, while FIIs owned 14.23 per cent, DIIs 4.66 per cent. (Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.) Download The Economic Times News App to get Daily Market Updates & Live Business News….morelessPick the best stocks for yourself Powered by 5 mins read3 mins read3 mins read2 mins read2 mins read3 mins read4 mins read3 mins read

Leave a Reply

Your email address will not be published. Required fields are marked *